Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 6

Treatment options and patient perspectives in the management of fibromyalgia: future trends

Authors Kim Lawson

Published Date November 2008 Volume 2008:4(6) Pages 1059—1071

DOI http://dx.doi.org/10.2147/NDT.S3468

Published 16 November 2008

Kim Lawson

Biomedical Research Centre, Sheffield Hallam University, Faculty of Health and Wellbeing, Sheffield, UK

Abstract: Fibromyalgia (FM) is a common, complex, and difficult to treat chronic widespread pain disorder, which usually requires a multidisciplinary approach using both pharmacological and non-pharmacological (education and exercise) interventions. It is a condition of heightened generalized sensitization to sensory input presenting as a complex of symptoms including pain, sleep dysfunction, and fatigue, where the pathophysiology could include dysfunction of the central nervous system pain modulatory systems, dysfunction of the neuroendocrine system, and dysautonomia. A cyclic model of the pathophysiological processes is compatible with the interrelationship of primary symptoms and the array of postulated triggers associated with FM. Many of the molecular targets of current and emerging drugs used to treat FM have been focused to the management of discrete symptoms rather than the condition. Recently, drugs (eg, pregabalin, duloxetine, milnacipran, sodium oxybate) have been identified that demonstrate a multidimensional efficacy in this condition. Although the complexity of FM suggests that monotherapy, non-pharmacological or pharmacological, will not adequately address the condition, the outcomes from recent clinical trials are providing important clues for treatment guidelines, improved diagnosis, and condition-focused therapies.

Keywords: fibromyalgia, pain, sleep dysfunction, fatigue, exercise, pharmacological treatments

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication

Jyothi KR, Beloor J, Jo A, Nguyen MN, Choi TG, Kim JH, Akter S, Lee SK, Maeng CH, Baik HH, Kang I, Ha J, Kim SS

International Journal of Nanomedicine 2015, 10:903-921

Published Date: 30 January 2015

Bioavailability of nanoemulsified conjugated linoleic acid for an antiobesity effect

Kim D, Park JH, Kweon DJ, Han GD

International Journal of Nanomedicine 2013, 8:451-459

Published Date: 4 February 2013

Biofunctionalization of a titanium surface with a nano-sawtooth structure regulates the behavior of rat bone marrow mesenchymal stem cells

Zhang WJ, Li ZH, Liu Y, Ye DX, Li JH, Xu LY, Wei B, Zhang XL, Liu XY, Jiang XQ

International Journal of Nanomedicine 2012, 7:4459-4472

Published Date: 13 August 2012

Use of loteprednol for routine prophylaxis after photorefractive keratectomy

Mifflin MD, Leishman LL, Christiansen SM, Sikder S, Hsu M, Moshirfar M

Clinical Ophthalmology 2012, 6:653-659

Published Date: 1 May 2012

Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction

Carreño E, Portero A, Galarreta DJ, Herreras JM

Clinical Ophthalmology 2012, 6:637-644

Published Date: 27 April 2012

Management of dysfunctional uterine bleeding based on endometrial thickness

Ozgul Muneyyirci-Delale, Anuja Gupta, Cynthia Abraham, et al.

International Journal of Women's Health 2010, 2:297-302

Published Date: 1 September 2010

Treatment of refractory complex partial seizures: role of vigabatrin

Elizabeth J Waterhouse, Kimberly N Mims, Soundarya N Gowda

Neuropsychiatric Disease and Treatment 2009, 5:505-515

Published Date: 6 October 2009

The cognitive impact of anticholinergics: A clinical review

Noll Campbell, Malaz Boustani, Tony Limbil, Carol Ott, et al.

Clinical Interventions in Aging 2009, 4:225-233

Published Date: 13 May 2009

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes

Marc K Israel, Eva Istvan, Michelle A Baron

Vascular Health and Risk Management 2008, 4:1167-1178

Published Date: 2 September 2008

Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women

Andrea Riccardo Genazzani, Nicola Pluchino, Francesca Bernardi, Manolo Centofanti, Michele Luisi

Neuropsychiatric Disease and Treatment 2006, 2:299-307

Published Date: 10 October 2006